BENGALURU (Reuters): Johnson & Johnson said late Thursday (July 1) that its single-shot Covid-19 vaccine showed strong promise against the Delta variant and other emerging strains and also provided durable protection against the infection more broadly.
Data showed that the durability of immune response for recipients of its vaccine lasted at least eight months, the healthcare company said, adding that its vaccine was 85% effective and could also help prevent hospitalization and death.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!